Clinical trial
Alleviant ALLAY-HF Study
NCT05685303
Study timeline
Study start (actual)2023-01-10Date precision: day
Registry last updated2026-08-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
Alleviant ALV1 SystemDEVICE
Sham-ControlOTHER
Sponsors & collaborators
Alleviant Medical, Inc.lead sponsor
Mapped research locations
BarcelonaSpain5New YorkNew York, United States3BostonMassachusetts, United States2MontrealQuebec, Canada2WroclawPoland2ChicagoIllinois, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1San FranciscoCalifornia, United States1MadridSpain1SeattleWashington, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05685303 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.